MetLife Investment Management’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-24,907
| Closed | -$595K | – | 2525 |
|
|
2021
Q1 | $595K | Sell |
24,907
-5,849
| -19% | -$140K | 0.01% | 1425 |
|
|
2020
Q4 | $449K | Hold |
30,756
| – | – | ﹤0.01% | 1538 |
|
|
2020
Q3 | $437K | Hold |
30,756
| – | – | ﹤0.01% | 1440 |
|
|
2020
Q2 | $452K | Buy |
30,756
+4,406
| +17% | +$64.8K | 0.01% | 1440 |
|
|
2020
Q1 | $109K | Hold |
26,350
| – | – | ﹤0.01% | 2025 |
|
|
2019
Q4 | $127K | Hold |
26,350
| – | – | ﹤0.01% | 2206 |
|
|
2019
Q3 | $160K | Hold |
26,350
| – | – | ﹤0.01% | 2070 |
|
|
2019
Q2 | $171K | Hold |
26,350
| – | – | ﹤0.01% | 2126 |
|
|
2019
Q1 | $187K | Hold |
26,350
| – | – | ﹤0.01% | 2013 |
|
|
2018
Q4 | $128K | Hold |
26,350
| – | – | ﹤0.01% | 2168 |
|
|
2018
Q3 | $194K | Hold |
26,350
| – | – | ﹤0.01% | 2098 |
|
|
2018
Q2 | $168K | Hold |
26,350
| – | – | ﹤0.01% | 2001 |
|
|
2018
Q1 | $143K | Buy |
+26,350
| New | +$143K | ﹤0.01% | 2065 |
|